Skip to main content
takacs tamas - pancreas belgyogyaszata


1. Bhatia M: Apoptosis versus necrosis in acute pancreatitis. Am J Phys Gastrointest Liver
Phys 2004, 286: G189-G196.
2. Bhatia M: Apoptosis of pancreatic acinar cells in acute pancreatitis: is it good or bad? J Cell
Mol Med 2004, 8: 402-409.
3. Hartwig W, Werner J, Warshaw AL et al: Membrane-bound ICAM-1 is upregulated by
trypsin and contributes to leukocyte migration in acute pancreatatis. Am J Physiol Gastrointest
Liver Physiol 2004, 287: G1194-99.
4. Wittel UA, Rau B, Gansauge F et al: Influence of PMN leukocyte-mediated pancreatic
damage on the systemic immune response in severe acute pancreatitis in rats. Dig Dis Sci
2004, 49: 1348-57.
5. Oruc N, Ozutemiz AO, Yukselen V et al: Infliximab: A new therapeutic agent in acute
pancreatitis? Pancreas 2004, 28 (1): e1-e18.
6. Yang YL, Li JP, Li KZ et al: Tumor necrosis factor α antibody prevents brain damage of
rats with acute necrotizing pancreatitis. World J Gastroenterol 2004, 10: 2898-900.
7. Chen ZQ, Tang YQ, Zhang Y et al: Adenoviral transfer of human interleukin-10 gene in
lethal pancreatitis. World J Gastroenterol 2004, 10: 3021-25.
8. Goldacre MJ, Roberts SE: Hospital admission for acute pancreatitis ina n English
population, 1963-98: database study of incidence and mortality. BMJ 2004, 328: 1466-69.
9. Andersson R, Andersson B, Haraldsen P et al: Incidence, management and recurrence rate
of acute pancreatitis. Scand J Gastroenterol 2004, 39: 891-94.
10. Morton C, Klatsy AL, Udaltsova N: Smoking, coffee and pancreatitis. Am J Gastroenterol
2004, 99: 729-30.
11. Choudari CP, Imperiale TF, Sherman S et al: Risk of pancreatitis with mutation of the
cystic fibrosis gene. Am J Gastroenterol 2004, 99: 1358-63.
12. Gelrud A, Sheth S, Banerjee S et al: Analysis of cystic fibrosis gener product (CFTR)
function in patients with pancreas divisum and recurrent acute pancreatitis. Am J
Gastroenterol 2004, 99: 1557-62.
13. Kamisawa T: Clinical significance of the minor duodenal papilla and accessory pancreatic
duct. J Gastroenterol 2004, 39: 605-15.
14. Howard TJ, Moore SA, Saxena R et al: Pancreatic duct strictures are a common cause of
recurrent pancreatitis after succesful management of pancreatic necrosis. Surgery 2004, 136:
15. Mentula P, Kylanpaa ML, Kemppainen E, Jansson SE, Sarna S, Puolakkainen P,
Haapiainen R, Repo H: Br J Surg 2005, 92: 68-75.
16. Johnson CD, Lempinen M, Imrie CW, Puolakkainen P, Kemppainen P, Carter R, McKay
C: Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Br J Surg
2004, 91: 1027-33.
17. Rau B, Krüger CM, Schilling MK: Procalcitonin: improved biochemical severity
stratification and postoperative monitoring in severe abdominal inflammation and sepsis.
Langenbecks Arch Surg 2004, 389: 134-44.
18. Johnson CD, Abu-Hilal M, Members of the British Acute Pancreatitis Study Group:
Persistent organ failure during the first week as a marker of fatal outcome in acute
pancreatitis. Gut 2004, 53: 1340-44.
19. McKay CJ, Imrie CW: The continuing challange of early mortality in acute pancreatitis
2004, 91: 1243-44.
20. Tenner S: Initial management of acute pancreatitis. Am J Gastroenterol 2004, 99: 2489-94.
21. Brown A: Prophylactic antibiotic use in severe acute pancreatitis: hemlock, help or hype?
Gastroenterology 2004, 126: 1195-98.
22. Isenmann R, Rünzi M, Kron S et al: Prophylactic treatment in patients with predicted
severe acute pancreatitis: A placebo-controlled, double-blind trial. Gastroenterology 2004,
126: 997-1004.
23. Machala W, Wachowicz N, Komorowska A et al: The use of drotrecogin alfa (activated) in
severe sepsis during acute pancreatitis – two case studies. Med Sci Monit 2004, 10: CS31-36.
24. Seta T, Noguchi Y, Shimada T et al: Treatment of acute pancreatitis with protease
inhibitors: a meta-analysis. Eur J Gastroenterol Hepatol 2004, 16: 1287-93.
25. Marik PE, Zaloga GP: Mata-analysis of parenteral nutrition versus enteral nutrition in
patients with acute pancreatitis. BMJ 2004, 326: 1407-12.
26. Besselink MGH, Timmerman HM, Buskens E et al: Probiotic prophylaxis in patients with
predicted severe acute pancreatitis (PROPATRIA): design and rationale of double-blind,
placebo-controlled randomised multicenter trial. BMC Surgery 2004, 4: 12-18.
27. Szentkereszty Z, Czimbalmos A, Kotán R et al: Quality of life following acute necrotizing
pancreatitis. Hepato-Gastroenterol 2004, 51: 1172-74.
28. Jaster R: Molecular regulation of pancreatic stellate cell function. Molecular Cancer 2004,
3: 26-34.
29. Madro A, Celinski K, Stomka M: The role of pancreatic stellate cells and cytokines int he
development of chronic pancreatitis. Med Sci Monit 2004, 10: RA166-170.
30. Oruc N, Lamb J, Kutlu OC et al: The functional angiotensin converting enzyme gene I/D
polymorphism does not alter susceptibility to chronic pancreatitis. J Pancreas 2004, 5: 457-63.
31. Watanabe S, Nagashio Y, Asaumi H et al: Pressure activates rat pancreatic stellate cells.
Am J Physiol Gastrointes Liver Physiol 2004, 287: G1175-83.
32. Otsuki M: Chronic pancreatitis. The problem of diagnostic criteria. Pancreatology 2004,
4: 28-41.
33. Kim KP, Kim MH, Song MH et al: Autoimmun chronic pancreatitis. Am J Gastroenterol
2004, 99: 1605-16.
34. Cello JP: Alcoholic patient with constant abdominal pain and normal amylase.
Gastroenterology 2004, 126: 895-902.
35. Varlaan M, Te Morsche RHM, Roelofs HMJ et al: Genetic polymorphism in alcoholmetabolizing
enzymes and chronic pancreatitis. Alcohol and Alcoholism 2004, 39: 20-24.
36. Schneider A, Barmada MM, Slivka A et al: Clinical characterization of patients with
idiopathic chronic pancreatitis and SPINK1 mutation. Scand J Gastroenterol 2004, 39: 903-4.
37. Chandak GR, Idris MM, Reddy DN et al: Absence of PRSS1 mutations and association of
SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis. Gut
2004, 53: 723-28.
38. Teich N, Maréchal CL, Kukor Z et al: Interaction between trypsinogen isoforms in
genetically determined pancreatitis: Mutation E79K in cationic trypsin (PRSS1) causes
increased transactivation of anionic trypsinogen (PRSS2). Hum Mutat 2004, 23: 22-31.
39. Casellas F, Guamer L, Antolin M et al: Hydrogen Breath test with low-dose rice flour for
assessment of exocrine pancreatic insufficiency. Pancreas 2004, 29: 4-8.
40. Forsmark CE: Chronic pancreatitis and malabsorption. Am J Gastroenterol 2004, 99:
41. Dumasy V, Delhaye M, Cotton F et al: Fat malabsorption screening in chronic
pancreatitis. Am J Gastroenterol 2004, 99: 1350-54.
42. Keller J, Layer P: Pancreatic enzyme supplementation therapy. Curr Treatment Options
Gastroenterol 2003, 6: 369-374.
43. Cartmell MT, O
,Reilly DA, Porter C et al: A double-blind placebo-controlled trial of a
leukotriene receptor antagonist in chronic pancreatitis in humans. J Hepatobil Pancreat Surg
2004, 11: 255-59.
44. Withcomb DC: Inflammation and cancer V. Chronic pancreatitis and pancreatic cancer.
Am J Physiol Gastrointest Liver Physiol 2004, 287: G315-G319.
45. Wehler M, Nichterlein R, Fischer B et al: Factors associated with health-related quality of
life in chronic pancreatitis. Am J Gastroenterol 2004, 99: 138-46.